BioSpace News Archive

Research and real-world evidence support the use across a range of leukemias and lymphomas and demonstrate utility in multiple tissue types, including blood and bone marrow Late breaker presentation of CANDOR study includes secondary endpoint of improved NGS MRD negative Complete Response Rate at 12 months

Exact Sciences Corp. announced Dr. David Ahlquist, co-inventor of Cologuard® and emeritus professor of medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, has been named a Fellow of the National Academy of Inventors.

Update adds over 100 new tumor models and 150 new bioinformatic data sets, increasing translational power of the Compendium

To obtain real-world data on the use of RADICAVA, MTPA engaged Soleo Health, a provider of home and alternative-site infusions and specialty pharmacy services in the U.S., to share information from 163 patients receiving RADICAVA for at least three months

Social Innovation Lab, Founders’ Scholarship, and MediEd - New Additions to Medidata’s Corporate Social Responsibility Programs

Prioritizing Development of Reloxaliase for Patients with Enteric Hyperoxaluria

Ardelyx, Inc. announced that it has commenced an underwritten public offering of up to $80,000,000 of shares of its common stock.

The first UK clinical trial site for the treatment of diabetic patients with chronic limb-threatening ischemia (CLI) using a novel patient-specific regenerative therapy has opened for patient recruitment at the University Hospital of Wales in Cardiff

The evidence review examined all available studies on use of telemedicine for several neurologic conditions

RubrYc’s SAB will leverage synergistic expertise in structural and computational biology, translational sciences, and market and clinical insights.